Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q15744 (
C/EBP epsilon
)
82
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of the N-linked oligosaccharide inhibitors swainsonine and N-butyldeoxynojirimycin (NB-DNJ) on granulopoiesis was investigated using human bone marrow cells in in vitro liquid and agar cultures. The addition of the inhibitors into cultures containing granulocyte colony-stimulating factor (G-CSF) suppressed maturation from myelocytes into mature neutrophils. Swainsonine did not induce apoptosis, but NB-DNJ induced considerable apoptosis, especially in the presence of G-CSF. This result indicated that the decrease of mature neutrophils by swainsonine was not because of cell degeneration. In the case of NB-DNJ, it was thought to be because of both maturation suppression and apoptosis. In a colony-forming unit-granuloid (CFU-G) colony assay, the number of colonies was increased in the presence of the inhibitors, but the morphology of colonies was predominantly compact, or immature. The inhibitors also suppressed the expressions of mRNAs of
CCAAT/enhancer binding protein epsilon
(C/EBPepsilon) and
G-CSF receptor
as markers of terminal neutrophil maturation. These findings suggested that the incompleteness of N-linked oligosaccharide leads to the suppression of terminal neutrophil maturation.
...
PMID:Suppressive effects of swainsonine and N-butyldeoxynojirimycin on human bone marrow neutrophil maturation. 1069 3
Granulocyte colony-stimulating factor (G-CSF) is a major cytokine that regulates proliferation and differentiation of myeloid cells, although the underlying mechanisms by which G-CSF controls myeloid differentiation are largely unknown. Differentiation of hematopoietic cells is regulated by lineage-specific transcription factors, and gene-targeting studies previously revealed the critical roles of CCAAT/enhancer-binding protein (C/EBP) alpha and
C/EBP epsilon
, respectively, in the early and mid-late stages of granulocyte differentiation. The expression of
C/EBP epsilon
in 32Dcl3 cells and FDCP1 cells expressing mutant G-CSF receptors was examined and it was found that G-CSF up-regulates
C/EBP epsilon
. The signal for this expression required the region containing the first tyrosine residue of
G-CSF receptor
. Dominant-negative signal transducers and activators of transcription 3 blocked G-CSF--induced granulocytic differentiation in 32D cells but did not block induction of
C/EBP epsilon
, indicating that these proteins work in different pathways. It was also found that overexpression of
C/EBP epsilon
greatly facilitated granulocytic differentiation by G-CSF and, surprisingly, that expression of
C/EBP epsilon
alone was sufficient to make cells differentiate into morphologically and functionally mature granulocytes. Overexpression of c-myc inhibits differentiation of hematopoietic cells, but the molecular mechanisms of this inhibition are not fully understood. In 32Dcl3 cells overexpressing c-myc that do not differentiate by means of G-CSF, induction of
C/EBP epsilon
is completely abrogated. Ectopic expression of
C/EBP epsilon
in these cells induced features of differentiation, including changes in nuclear morphologic characteristics and the appearance of granules. These data show that
C/EBP epsilon
constitutes a rate-limiting step in G-CSF-regulated granulocyte differentiation and that c-myc antagonizes G-CSF-induced myeloid differentiation, at least partly by suppressing induction of
C/EBP epsilon
. (Blood. 2001;98:897-905)
...
PMID:Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein epsilon. 1149 31